Maganti, Harinad B <br/><br/>
Targeting the MTF2-MDM2 Axis Sensitizes Refractory Acute Myeloid Leukemia to Chemotherapy.  [electronic resource] 

 -  Cancer discovery  11 2018 
 - 1376-1389 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2159-8290 
<br/><br/><label>Standard No.: </label>10.1158/2159-8290.CD-17-0841  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antibiotics, Antineoplastic--pharmacology<br/>Daunorubicin--pharmacology<br/>Drug Resistance, Neoplasm<br/>Humans<br/>Leukemia, Myeloid, Acute--drug therapy<br/>Mice<br/>Mice, Inbred NOD<br/>Mice, SCID<br/>Polycomb Repressive Complex 2--antagonists & inhibitors<br/>Proto-Oncogene Proteins c-mdm2--antagonists & inhibitors<br/>Tumor Cells, Cultured<br/>Tumor Suppressor Protein p53--genetics<br/>Xenograft Model Antitumor Assays